📰 Page Interactive Data News
Page 3 - Page Interactive Data News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Page Interactive Data. Real-time updates on events, politics, business and more.
April 11, 2023
Item 7.01. Regulation FD Disclosure. On April 11, 2023, we issued a press release announcing that we and Diversified Healthcare Trust, or DHC, entered into an Agreement and Plan of Merger, or... | April 11, 2023
April 11, 2023
Item 3.01. Notice of Delisting or Failure To Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On April 5, 2023, Titan Pharmaceuticals, Inc. received a notice from the Listing... | April 11, 2023
April 6, 2023
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT ... | April 6, 2023
March 30, 2023
United States SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT ... | March 30, 2023
March 29, 2023
Item 2.02 Results of Operations and Financial Condition On March 29, 2023, Aerovate Therapeutics, Inc. announced its financial results for the fourth quarter and year ended December 31, 2022. A copy... | March 29, 2023
March 28, 2023
Item 8.01 Other Events. Camden National Corporation issued a press release on March 28, 2023, declaring a quarterly dividend of $0.42 per share payable on April 28, 2023 to its shareholders of... | March 28, 2023
March 2, 2023
Item 7.01. Regulation FD Disclosure. On February 27, 2023, The Williams Companies, Inc. issued a press release announcing that it had priced the Offering . A copy of the press release is furnished... | March 2, 2023
January 31, 2023
Item 2.02 Results of Operations and Financial Condition. On January 31, 2023, CorVel Corporation issued a press release announcing its financial results for the three and nine months ended... | January 31, 2023
January 18, 2023
Item 2.02 Results of Operations and Financial Condition. On January 17, 2023, Nine Energy Service, Inc. filed a preliminary prospectus supplement to its effective shelf registration statement on... | January 17, 2023
January 10, 2023
Item 2.02 Results of Operations and Financial Condition. On January 10, 2023, Kymera Therapeutics, Inc. issued a press release announcing its preliminary cash balance as of December 31, 2022,... | January 10, 2023